Actelion Pharmaceuticals Sweden AB Fili is part of the Actelion group, which is known for its specialization in the development and production of pharmaceuticals. The company focuses on innovative treatments, particularly in areas such as cardiovascular diseases and rare diseases. Actelion has a strong research focus and invests significantly in the development of new medicines to meet unmet medical needs.
The company has an international presence and is part of a larger network of research and development centres. Actelion Pharmaceuticals Sweden AB Fili contributes to the global effort to improve patient care and quality of life through its products. With a commitment to scientific innovation, the company works continuously to develop and optimize its medicines.